| Nordic Pancreatic Cancer Trial (NorPACT) - 1 (NCT02919787) | Oslo University Hospital | 2016-09-01 |
| Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy (NCT02954302) | The First Affiliated Hospital of Xiamen University | 2016-09-01 |
| Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction (NCT03054987) | AdventHealth | 2016-09-01 |
| Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers (NCT02442739) | Cedars-Sinai Medical Center | 2016-08-15 |
| Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities (NCT02887599) | Yonsei University | 2016-08-08 |
| Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer (NCT02868632) | NYU Langone Health | 2016-08-07 |
| Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers (NCT02584244) | Lumicell, Inc. | 2016-08-04 |
| Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. (NCT02332863) | University of Colorado, Denver | 2016-08-03 |
| Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer (NCT02851381) | Jonsson Comprehensive Cancer Center | 2016-08-01 |
| Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer (NCT02894944) | Seoul National University Hospital | 2016-08-01 |
| Programs To Support You During Chemotherapy (NCT02489422) | Wake Forest University Health Sciences | 2016-08-01 |
| Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer (NCT02648282) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-18 |
| FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial (NCT02578732) | Brown University | 2016-07-12 |
| Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study (NCT03017599) | Yonsei University | 2016-07-11 |
| BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients (NCT02650804) | BPGbio | 2016-07-06 |
| Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow (NCT03551951) | University of Missouri-Columbia | 2016-07-01 |
| Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer (NCT05399394) | Campus Bio-Medico University | 2016-07-01 |
| A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) (NCT02576665) | Tocagen Inc. | 2016-07-01 |
| Efficacy and Safety of PARPi to Treat Pancreatic Cancer (NCT02511223) | Sheba Medical Center | 2016-07-01 |
| Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer (NCT02934984) | Samsung Medical Center | 2016-07-01 |
| Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers (NCT02838836) | University of Missouri-Columbia | 2016-07-01 |
| Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle (NCT02872831) | Thomas Jefferson University | 2016-07-01 |
| A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors (NCT02791334) | Eli Lilly and Company | 2016-06-29 |
| Epidural Analgesia Use in Pancreatic Resections (NCT02681796) | Washington University School of Medicine | 2016-06-07 |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT02608229) | Washington University School of Medicine | 2016-06-06 |
| The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT. (NCT02777463) | Wakayama Medical University | 2016-06-01 |
| Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer (NCT02948309) | Karolinska University Hospital | 2016-06-01 |
| Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers (NCT02777710) | Centre Leon Berard | 2016-06-01 |
| Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis (NCT02841800) | National Taiwan University Hospital | 2016-06-01 |
| EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic Cancer (NCT02682082) | Centre hospitalier de l'Université de Montréal (CHUM) | 2016-05-27 |
| Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable (NCT02818907) | Centre Hospitalier Universitaire de Besancon | 2016-05-19 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle (NCT02678442) | Mayo Clinic | 2016-05-16 |
| Preoperative Exercise in Pancreatic Cancer (NCT02648880) | University of Colorado, Denver | 2016-05-10 |
| Ultrasound Monitoring of Abdominal Soft Tissue (NCT02722616) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-01 |
| Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer (NCT02745847) | Changhai Hospital | 2016-05-01 |
| Two-in-one Covered and Uncovered Metal Stent (NCT04337333) | Ajou University School of Medicine | 2016-05-01 |
| Post-operative Drainage After Pancreaticoduodenectomy (NCT05270564) | Linkoeping University | 2016-05-01 |
| CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer (NCT04560270) | Poitiers University Hospital | 2016-04-25 |
| Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer (NCT02713529) | AmMax Bio, Inc. | 2016-04-14 |
| A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer (NCT02428270) | University Health Network, Toronto | 2016-04-01 |
| Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer (NCT03403049) | Montefiore Medical Center | 2016-04-01 |
| Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas (NCT02598349) | Proton Collaborative Group | 2016-04-01 |
| Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas (NCT02451982) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-28 |
| ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer (NCT02514031) | University of Texas Southwestern Medical Center | 2016-03-24 |
| Germline Mutations in Pancreatic Adenocarcinoma (NCT03982446) | Hellenic Cooperative Oncology Group | 2016-03-01 |
| Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer (NCT02685228) | The First Hospital of Jilin University | 2016-03-01 |
| A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma (NCT02706782) | Shanghai GeneChem Co., Ltd. | 2016-03-01 |
| A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer (NCT02713984) | Zhi Yang | 2016-03-01 |
| Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer (NCT02718859) | Fuda Cancer Hospital, Guangzhou | 2016-03-01 |
| Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma (NCT02974764) | Johns Hopkins University | 2016-03-01 |
| Project Survival-Prospective Biomarker Discovery (NCT02781012) | Pancreatic Cancer Research Team | 2016-03-01 |
| Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer (NCT02546531) | Washington University School of Medicine | 2016-02-03 |
| IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer (NCT02734680) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2016-02-01 |
| Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer (NCT02704143) | Changhai Hospital | 2016-02-01 |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer (NCT02581501) | Stamford Hospital | 2016-02-01 |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System (NCT02662348) | Yi Miao | 2016-02-01 |
| Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) (NCT02702986) | Universita di Verona | 2016-02-01 |
| Exercise and Nutrition to Improve Pancreatic Cancer Outcomes (NCT03256201) | University of Oklahoma | 2016-02-01 |
| Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers (NCT02639026) | Abramson Cancer Center at Penn Medicine | 2016-01-26 |
| Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors (NCT02646748) | Incyte Corporation | 2016-01-25 |
| Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy (NCT03016637) | Odense University Hospital | 2016-01-01 |
| A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction (NCT02659852) | Yonsei University | 2016-01-01 |
| American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry (NCT02674100) | University of Louisville | 2016-01-01 |
| Study of SBP-101 in Pancreatic Cancer (NCT02657330) | Panbela Therapeutics, Inc. | 2016-01-01 |
| Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies (NCT02672917) | BioNTech Research & Development, Inc. | 2016-01-01 |
| Radiomics in Pancreatic Cancer (NCT05658679) | Ruijin Hospital | 2016-01-01 |
| K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability (NCT02720666) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2016-01-01 |
| A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer (NCT02643498) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (NCT02433626) | Critical Outcome Technologies Inc. | 2015-12-01 |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267) | Hoffmann-La Roche | 2015-11-19 |
| Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer (NCT02293954) | City of Hope Medical Center | 2015-11-11 |
| Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training (NCT03525353) | The University of Texas Health Science Center, Houston | 2015-11-01 |
| A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies (NCT02498665) | Sumitomo Pharma America, Inc. | 2015-11-01 |
| A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients (NCT02854072) | Samsung Pharmaceutical Co., Ltd. | 2015-11-01 |
| A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma (NCT02539537) | UNICANCER | 2015-10-23 |
| Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma (NCT02551991) | Ipsen | 2015-10-19 |
| Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia (NCT02580422) | Indiana University | 2015-10-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso (NCT02580747) | Chinese PLA General Hospital | 2015-10-01 |
| Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma (NCT02588443) | Abramson Cancer Center at Penn Medicine | 2015-10-01 |
| TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors (NCT02574663) | TG Therapeutics, Inc. | 2015-09-11 |
| Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers (NCT02526017) | Five Prime Therapeutics, Inc. | 2015-09-08 |
| Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer (NCT02358161) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-09-01 |
| Safety Study of MGD009 in B7-H3-expressing Tumors (NCT02628535) | MacroGenics | 2015-09-01 |
| Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects (NCT02651727) | Verastem, Inc. | 2015-09-01 |
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma (NCT02352831) | Washington University School of Medicine | 2015-08-31 |
| Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) (NCT02461836) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2015-08-01 |
| Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery (NCT02900677) | National Taiwan University Hospital | 2015-08-01 |
| Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer (NCT02548169) | Baylor Research Institute | 2015-08-01 |
| Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer. (NCT02506803) | Wakayama Medical University | 2015-07-01 |
| Translational Research on Locally Advanced Pancreatic Adenocarcinoma (NCT03009253) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2015-07-01 |
| Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain (NCT02510066) | Shanghai Cancer Hospital, China | 2015-07-01 |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers (NCT02349412) | Alliance for Clinical Trials in Oncology | 2015-06-25 |
| Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer (NCT02646462) | Michael Bau Mortensen | 2015-06-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 (NCT02541370) | Chinese PLA General Hospital | 2015-06-01 |
| Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas (NCT02514928) | Fudan University | 2015-06-01 |
| Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining (NCT02486497) | Seoul National University Hospital | 2015-06-01 |
| EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer (NCT02695966) | Cambridge University Hospitals NHS Foundation Trust | 2015-05-01 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer (NCT02449967) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |